Innovator’s Pitch Challenge

AI-Leveraging Life Science

Wednesday, March 15
3:00 – 4:00pm ET

CRISPR, a Nobel Prize-winning gene-editing tool, has the potential to revolutionize therapeutics, diagnostics, agriculture, and academic research. Unfortunately, limited visibility into the editing process is hindering progress. To address this issue, CRISPR QC has developed the world’s first and only CRISPR Analytics Platform, which employs the proprietary CRISPR-Chip to uncover insights into the biochemical factors that drive gene-editing success. Through collaboration with our customers and the National Institute of Standards and Technology, we are establishing the CRISPR Analytics Platform as the foundational standard for predicting gene editing outcomes and unlocking the full potential of gene editing.

Contact Us:

Ross Bundy